Common Sense Oncology: 2026 Cancer Health Services Research Fellowship

Access a PDF version of the Fellowship Posting Here The Sinclair Cancer Research Institute (SCRI) at Queen’s University in Kingston, Canada and Common Sense Oncology invite applications for a one-year Cancer Health Services Research Fellowship with an expected start date of July 1, 2026. This fellowship will provide hands-on training (more…)

Should Canadian provincial/territorial cancer registries collect race/ethnicity and sociodemographic data? A survey study.

La version française suit ARCC is assisting in recruitment for this study targeted at Canadian Cancer Care Providers. Many studies have noted disparities in cancer care and outcomes in marginalized populations. Leading cancer societies in the United States have recommended standardized collection of data on race, ethnicity, gender identity and other (more…)

APPLICATIONS NOW OPEN Fall 2025 Early Career Researcher Workshop (CIHR)

The CIHR Institute of Cancer Research is pleased to announce the open call for applications for its 2025 Early Career Researcher (ECR) Workshop, in partnership with the Canadian Cancer Research Alliance, Canadian Cancer Society, Cancer Research Society, Ontario Institute for Cancer Research, and Terry Fox Research Institute. The 2025 ECR (more…)
CIHR logo

CIHR Health System Impact Fellowship 2026

The Health System Impact (HSI) Fellowship provides an embedded research opportunity for highly qualified doctoral trainees and post-doctoral researchers studying health services and policy research (HSPR) (or related fields). This is a unique opportunity for awardees to: develop their embedded research experience and apply their research and analytic talents to (more…)

UofT RWE Bootcamp – Registration is open

Course Overview For full details and to register please visit https://www.pharmacy.utoronto.ca/programs/continuing-professional-development/RWE-Bootcamp  Explore Real World Evidence (RWE) in a 3-day program designed by experts and tailored for professionals seeking to enter or enhance their knowledge in this field. This program is set at a beginner or novice level. We will cover (more…)

Registration for CAHSPR 2025 is now open!

The 2025 CAHSPR Conference is being held from May 26-29, 2025 in Ottawa at the Delta Hotel. The 2025 conference theme is “Charting the Course for Health System Transformation”.  As the Cancer Theme Group for CAHSPR, ARCC will be hosting a specialized session at CAHSPR2025 discussing the use of Synthetic (more…)

2025 CCRA Patient Involvement in Cancer Research Program (PIP)

CCRA’s Patient Involvement in Cancer Research Program (known as PIP) will be offered this year as an in-person program. PIP is interwoven with the Canadian Cancer Research Conference (CCRC) and provides participants with an opportunity to learn about leading edge science and network with cancer researchers and trainees. Patients will be (more…)

CAPO 2025 – Registration Open (Early Bird Deadline Feb. 14/25)

Save-the-Date: The 2025 CAPO Conference is being held April 23-25, at Hilton Toronto, Ontario. Early bird registration rates are in effect through February 14th, 2025.  The mission of the Canadian Association of Psychosocial Oncology (CAPO) is to foster the science and practice of psychosocial oncology to improve the care for people (more…)

2025 CCTG Recognition Awards

The Canadian Cancer Trials Group is seeking nominations for the 2025 Recognition Awards honouring individuals who have contributed significantly to the mission and activities of the Group. CCTG is seeking nominations for the following Recognition Awards: Founder’s Award: Dr. Joseph Pater Excellence in Clinical Trials Research The Founder’s Award is (more…)

CDA – Consultation on Proposed Improvements to the Reimbursement Review Process

Please visit https://www.cda-amc.ca/consultation-proposed-improvements-reimbursement-review-process for full information on this opportunity. The drug Reimbursement Review process at Canada’s Drug Agency plays a critical role in the pathway that helps patients access new drugs. In June 2023, CDA signalled program improvements that could be explored or added to the process. Since that time, (more…)